FDA Ignores Tobacco Harm Reduction As Therapeutic Option – Experts
This article was originally published in The Tan Sheet
Executive Summary
FDA's tobacco product policies impede development of alternatives to smoking-cessation products with utility for harm reduction, according to an expert panel.
You may also be interested in...
New Products In Brief
Pfizer launches new line, extends Centrum
New Products In Brief
Pfizer launches new line, extends Centrum
New Products In Brief
Pfizer launches new line, extends Centrum